FV Pharma International Corp.
CIK 0001565220
Revenue (TTM)
$0
−100.0% YoY
Q3 Feb 2015
Net Income (TTM)
−$57.12K
−2,251.4% YoY
Q3 Feb 2015
EPS Diluted (TTM)
—
Q3 Feb 2015
Gross Margin
—
Q3 Feb 2015
Operating Margin
—
Q3 Feb 2015
Net Margin
—
Q3 Feb 2015
Free Cash Flow (TTM)
—
Q3 Feb 2015
Cash
$0
Q3 Feb 2015
Total Debt
—
Q3 Feb 2015
Shares Outstanding
250.8M sh
Q3 Feb 2015